FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News

Biosimilars Head Christl Leaving FDA

CDER Therapeutic Biologics and Biosimilars Staff director Leah Christl announces her departure to pursue other opportunities.

Federal Register

Rare Disease Drug Development Guide

Federal Register notice: FDA issues a draft guidance, Rare Diseases: Common Issues in Drug Development, to assist drug and biological sponsors in cond...

Federal Register

Guide on REMS Assessment: Planning and Reporting

Federal Register notice: FDA makes available a draft guidance entitled REMS Assessment: Planning and Reporting.

Medical Devices

Terrific/Medex Recalls Blood Thinner Test Strips

Terrific Care/Medex Supply recalls all lots of Roche Diagnostics CoaguChek XS PT Test Strips that were manufactured 10/2017 to 5/2018 due to inaccurat...

Human Drugs

West Pharma Recalls Vial2Bag Fluid Transfer System

West Pharmaceutical Services recalls its Vial2Bag fluid transfer system that was manufactured between 3/15/2016 and 1/8/2019 due to the possibility th...

Human Drugs

Congressmen Introduce Bill to Prevent Generic Drug Delays

Congressmen Kurt Schrader (D-OR) and Earl L. Carter (R-GA) introduce legislation aimed at keeping drug prices down by increasing competition in the ge...

Federal Register

Coordinating Antimicrobial Drug/Susceptibility Test Guide

Federal Register notice: FDA makes available a final guidance entitled Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility...

Federal Register

Guide on Device Safety/Performance-based Pathway

Federal Register notice: FDA issues a guidance, Safety and Performance Based Pathway, that discusses the agencys current thinking on expanding the con...

Federal Register

Guide on REMS Survey Methodologies

Federal Register notice: FDA releases a draft guidance entitled Survey Methodologies to Assess REMS Goals That Relate to Knowledge that gives informat...

Federal Register

Draft Guide on Drug Marketing Status Notifications

Federal Register notice: FDA makes available a draft guidance entitled Marketing Status Notifications Under Section 506I of the Federal Food, Drug, an...